Moreover, nicotinamide weakened the effect of 2-APQC on relieving myocardial hypertrophy, indicating that the treatment of myocardial hypertrophy by 2-APQC was dependent on SIRT3 activation (Fig. 3l). Here, SIRT3 is linked to cardiac hypertrophy.